ABCs Report: Streptococcus pneumoniae, 1998
This website is archived for historical purposes and is no longer being maintained or updated.
February 2, 2010: Content on this page kept for historical reasons.
Active Bacterial Core Surveillance (ABCs): Emerging Infections Program Network
Print-friendly version of this surveillance report [1 page]
ABCs Areas
California (San Francisco County); Connecticut; Georgia (20 county Atlanta area); Maryland (6 county Baltimore area); Minnesota (7 county Twin Cities area); New York (7 county Rochester area); Oregon (3 county Portland area); Tennessee (5 urban counties)
ABCs Population
The surveillance areas represent 17,383,935 persons. Source: U.S. Bureau of the Census, 1998
ABCs Case Definition
Invasive pneumococcal disease: isolation of Streptococcus pneumoniae from normally sterile site in resident of a surveillance area in 1998.
ABCs Methodology
Project personnel communicated at least monthly with contacts in all microbiology laboratories serving acute care hospitals in their area to identify cases. Standardized case report forms that include information on demographic characteristics, clinical syndrome, and outcome of illness were completed for each identified case. Pneumococcal isolates were collected and tested for susceptibility at reference laboratories using NCCLS methods. Regular laboratory audits assess completeness of active surveillance and detect additional cases.
All rates of invasive pneumococcal disease were calculated using U.S. Bureau of the Census postcensal population estimates for 1998. For national projections of cases, race- and age-specific rates of disease were applied from the aggregate surveillance area to the age and racial distribution of the 1998 U. S. population. Cases with unknown race were distributed by area based on reported race distribution for known cases within the eight age categories.
Reported ABCs Profiles
Race | No. | (Rate*) |
---|---|---|
White | 2,600 | (19.1) |
Black | 1,469 | (49.5) |
Other | 113 | (13.7) |
Unknown race (n=498) distributed among knowns.
* Cases per 100,000 population for ABCs areas.
Ethnicity | No. | (Rate*) |
---|---|---|
Hispanic | 131 | (17.1) |
Non-Hispanic | 1,725 | ------ |
Unknown | 2,326 | ------ |
*Cases per 100,000 population for ABCs areas
Citation
Centers for Disease Control and Prevention. 1999. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 1998.
Age (years) | Cases No. (Rate*) |
Deaths No. (Rate*) |
---|---|---|
<1 | 397 (165.3) | 5 (2.07) |
1 | 483 (202.5) | 3 (1.26) |
2-4 | 265 (36.9) | 0 (0.00) |
5-17 | 126 (4.0) | 3 (0.10) |
18-34 | 349 (8.1) | 15 (0.35) |
35-49 | 783 (17.9) | 86 (1.96) |
50-64 | 584 (24.2) | 75 (3.11) |
≥ 65 | 1,195 (60.5) | 198 (10.03) |
Total | 4,182 (24.1) | 385 (2.21) |
*Cases or deaths per 100,000 population for ABCs areas
Syndrome | No. | (%*) |
---|---|---|
Meningitis | 170 | (4.1) |
Bacteremia without focus | 1,612 | (38.5) |
Bacteremic pneumonia | 2,246 | (53.7) |
*Percent of cases
Antibiotic Susceptibility | S* % |
I† % |
R‡ % |
---|---|---|---|
Penicillin | 75.6 | 10.5 | 13.9 |
Cefotaxime | 85.9 | 8.0 | 6.1 |
Erythromycin | 84.9 | 0.2 | 15.0 |
TMP/Sulfa | 70.9 | 6.0 | 23.1 |
Levofloxacin | 99.8 | 0.0 | 0.2 |
Vancomycin | 100.0 | 0.0 | 0.0 |
Based on reference lab testing of 3,602 isolates.
* Susceptible; † Intermediate; ‡ Resistant
National Projections of Invasive Disease
Cases: 63,000 (23.3/100,000)
Deaths: 6,100 (2.2/100,000)
Healthy People 2010 Update
Objective: Decrease the incidence of invasive pneumococcal infections to 50 per 100,000 persons less than 5 years of age and to 46 per 100,000 persons aged 65 and older.
Age (year) | 2010 Objective | 1998 Rate* |
---|---|---|
< 5 | 50/100,000 | 87.6 |
≥ 65 | 46/100,000 | 60.2 |
*Projected cases per 100,000 U.S. population
Top of Page- Page last reviewed: February 2, 2010 (archived document)
- Content source: